FENC vs PCAR · rev $17.9M vs P/E 25, rev $33.66B
Fennec Pharmaceuticals Inc (FENC) versus PACCAR Inc (PCAR) — a side-by-side from cached financials, not a winner call.
Fennec Pharmaceuticals Inc (FENC) is a biotechnology company listed on US.
PACCAR Inc (PCAR) is a farm & heavy construction machinery company listed on NASDAQ.
Latest reported FENC revenue for 2026-06-30 was $17.9M. Net income was $2.0M. Revenue was up 18.3% from 2026-03-31 to 2026-06-30. FENC currently screens at market cap $302.2M.
Latest reported PCAR revenue for 2024-12-31 was $33.66B. Net income was $4.16B. Revenue was down 4.2% from 2023-12-31 to 2024-12-31. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
FENC currently screens at market cap $302.2M. PCAR currently screens at market cap $61.75B and trailing P/E 25.0.
Not investment advice. Open the FENC and PCAR stock pages for the full models.
Not investment advice.